Technical Analysis for SAVA - Cassava Sciences, Inc.

Grade Last Price % Change Price Change
F 29.59 -4.30% -1.33
SAVA closed down 4.3 percent on Monday, February 6, 2023, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: Feb 27
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Down Up

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
NR7 Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish -4.30%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.30%
MACD Bullish Signal Line Cross Bullish -4.30%
Inside Day Range Contraction -4.30%
Wide Bands Range Expansion -4.30%
Crossed Above 20 DMA Bullish -6.12%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 4 hours ago
Fell Below 200 DMA about 5 hours ago
200 DMA Support about 6 hours ago
60 Minute Opening Range Breakdown about 7 hours ago
Down 3% about 7 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Nervous System Disorders Psychiatry Transdermal Abnormal Psychology

Is SAVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 62.49
52 Week Low 13.84
Average Volume 1,512,037
200-Day Moving Average 29.67
50-Day Moving Average 33.33
20-Day Moving Average 31.33
10-Day Moving Average 28.98
Average True Range 2.82
RSI 45.65
ADX 15.04
+DI 24.80
-DI 22.20
Chandelier Exit (Long, 3 ATRs) 30.06
Chandelier Exit (Short, 3 ATRs) 34.18
Upper Bollinger Bands 37.20
Lower Bollinger Band 25.46
Percent B (%b) 0.35
BandWidth 37.48
MACD Line -1.03
MACD Signal Line -1.08
MACD Histogram 0.0475
Fundamentals Value
Market Cap 1.03 Billion
Num Shares 35 Million
EPS -0.27
Price-to-Earnings (P/E) Ratio -107.99
Price-to-Sales 0.00
Price-to-Book 11.31
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.87
Resistance 3 (R3) 32.06 31.49 31.49
Resistance 2 (R2) 31.49 30.91 31.40 31.36
Resistance 1 (R1) 30.54 30.55 30.26 30.35 31.24
Pivot Point 29.97 29.97 29.83 29.88 29.97
Support 1 (S1) 29.02 29.39 28.74 28.83 27.94
Support 2 (S2) 28.45 29.03 28.36 27.82
Support 3 (S3) 27.50 28.45 27.69
Support 4 (S4) 27.31